Overview

A Study to Assess the Effect of Food on the Pharmacokinetics of TY-9591 in Healthy Volunteers

Status:
Recruiting
Trial end date:
2021-08-30
Target enrollment:
Participant gender:
Summary
To assess the pharmacokinetics of TY-9591 tablets and Osimertinib Mesylate tablets after a single fasting administration and the effect of food on the pharmacokinetics of TY-9591 tablets in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
TYK Medicines, Inc
Treatments:
Complement Factor H
Osimertinib